|
FY2014
12 months to Dec 31, 2014
|
|
|---|---|
| Net loss attributable to controlling interests | |
| Adjustments to reconcile net loss to net cash used in operating activities: | |
| Depreciation | |
| Accretion of debt discount | |
| Debt Issuance costs | |
| Imputed Interest | |
| Non-Controlling Interest | |
| Services included in accounts payable to be satisfied in shares | |
| Issuance of common stock and warrants for services | |
| Stock based compensation | |
| Issuance of common stock for services and finders fee | |
| Issuance of convertible notes for services | |
| Beneficial conversion feature | |
| Issuance of preferred stock for interest | |
| Settlement-distribution agreement rights | |
| Debt Settlement liabilities and common shares in excess of recorded liabilities | |
| Issuance of stock and warrants for interest and financing costs | |
| Non-cash operating expenses and other charges | |
| Non-cash income-gain on settlements | |
| Options and warrants issued for services and wages | |
| Options exercised for services | |
| Contingently issued stock issued for services | |
| Warrants exercised for services | |
| Issuance of common stock for expenses paid by third party | |
| Issuance of common stock for settlement agreement | |
| Notes payable issued for expenses | |
| Notes payable converted to accrued wages | |
| Satisfaction of Syexia-in excess of accrual | |
| Change in variable common stock purchase options | |
| (Increase) decrease in prepaid expenses and other current assets | |
| (Increase) decrease in deposits and other assets | |
| Increase (decrease) in accrued interest | |
| Increase (decrease) in accounts payable | |
| Increase (decrease) in accrued expenses | |
| Increase (decrease) in accrued wages payable | |
| Increase (decrease) in advances-related parties | |
| Increase (decrease) in advances | |
| Increase (decrease) in insurance finance agreement | |
| Increase (decrease) in convertible debt-related parties and other | |
| Increase (decrease) in derivative liability | |
| Net cash used in operating activities | |
| Cash Flows From Investing Activities: | |
| Increase in leasehold improvements | |
| Acquisition of equipment | |
| Increase in intangible assets | |
| Net cash used in investing activities | |
| Cash Flows From Financing Activates: | |
| Proceeds of MedBridge Debt | |
| Proceeds from convertible debt-related party and other | |
| Payment for convertible debt-related party and other | |
| Proceeds from sale of common stock and warrants, net | |
| Proceeds from Revolving line of credit-related party | |
| Repayments of Revolving line of credit-related party | |
| Proceeds of sale of VGE securities to third parties, net | |
| Proceeds from notes payable | |
| Proceeds from exercise of options and warrants | |
| Proceeds from notes payable--related parties | |
| Net cash provided by financing activities | |
| Increase (decrease) in Cash | |
| Cash and cash equivalents, beginning of period | |
| Cash and cash equivalents, end of period | |
| SUPPLEMENT DISCLOSURE OF CASH FLOW INFORMATION Cash paid during the period for: | |
| Interest | |
| Income taxes | |
| NON-CASH TRANSACTIONS | |
| Issuance of common stock and warrants for convertible notes and interest | |
| Discount on indebtedness | |
| Reclassification of derivative liability to additional paid-in-capital | |
| Conversion of various accruals to convertible notes | |
| Issuance of common stock in satisfaction of accounts payable/notes/accruals | |
| Refinancing of convertible debt -related party Revolving line of credit | |
| Issuance of common shares in various debt settlements and partial satisfactions | |
| Issuance of unsecured convertible debentures for accounts payable | |
| Issuance of common stock for debt repayment-DMBM/Wonderland, net | |
| Noncontrolling interest, net | |
| Issuance of common stock for T & T legal and accrued interest | |
| Issuance of convertible note to acquire interest in unconsolidated subsidiary | |
| Issuance of common shares, options and warrants- V Clip acquisition | |
| Issuance of common shares - repurchase product royalty rights, China Market | |
| Issuance of common shares and warrants - Carcinotek acquisition | |
| Restructuring of convertible debentures | |
| Issuance (settlement) of unsecured convertible debentures - patents | |
| Issuance of common stock for debt paid by third party | |
| Issuance of common stock for debt and interest | |
| Issuance of common stock finders fee | |
| Warrants issued with convertible debentures and amendment of arrangement | |
| Transfer from derivative liabilities | |
| Issuance of warrant in partial consideration of notes payable | |
| Issuance of note in consideration of White Label acquisitions |
Loading...
